CTRI/2024/07/071115尚未招募Unknown
Double-Blind, three-Arm, randomized, intervention, prospective, in-use tolerability, clinical safety and efficacy study of teeth sensitivity toothpastes in healthy adult subjects: dentine hypersensitivity testing - Nil
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)Age will be 18 to 65 years (both inclusive) old at the time of consent.
- •2)Sex will be Healthy adult males and non-pregnant/non-lactating females.
- •3)Females of childbearing potential have a self-reported negative urine pregnancy test at the time of the screening visit and agree to follow an accepted method of birth control for the duration of the study such as condoms, foams, jellies, diaphragm, intrauterine device etc.
- •4)Subjects are generally in good general health as determined from recent medical history.
- •5)Subjects with a plaque index and gingivitis index score greater than 1 during screening.
- •6)Subjects having hypersensitive tooth during screening.
- •7)Subjects having root caries at time of screening.
- •8)Subjects having 6 present upper front teeth.
- •9)Anterior teeth without restorations.
- •10)No previous treatments performed on tooth.
- •11)Subjects who agree to discontinue the use of over-the-counter any teeth products throughout the trial.
- •12)Subjects who agree to refrain from the use of any oral products that may cause staining (chlorhexidine rinses, stannous fluoride toothpaste, etc.).
- •13)Agree not to participate in any other oral/dental product studies during the trial.
- •14)Agree to return for all scheduled visits and follow study procedures.
- •15)Subjects who are willing to complete all study procedures including study-related questionnaires and comply with study requirements.
排除标准
- •1)Subjects who are undergoing treatment for gingivitis, caries, dental plaque and sensitivity.
- •2)Subjects are present with fixed orthodontic appliances on the facial surfaces of the maxillary arch.
- •3)Subjects have dental crowns, veneers or composite restorations on gradable maxillary anterior teeth (canine to canine) or mandibular anterior teeth.
- •4)Subjects have any oral pathologies or gross neglect of home care requiring prompt treatment, including periodontal disease, as evidenced by purulent exudate, exposed root surfaces (generalized recession), tooth mobility, and/or other signs indicating that the integrity of the data collected for that subject might be compromised.
- •5)Subjects are present with any pre-existing oral or medical condition that the Investigator/designee determines may place the subject at increased health risk from study participation.
- •6)Subjects have meaningful malocclusion that would impact treatment or ease of viewing/scoring anterior teeth.
- •7)Subjects have teeth with severe or atypical intrinsic staining, such as that caused by tetracycline, fluorosis or hypo calcification.
- •8)Subjects have any known allergies to over-the-counter oral hygiene/ products.
- •9)Subjects have any known allergies to the trial product ingredients.
- •10)The subject must have participated in a clinical study with oral care or oral hygiene within 4 weeks before the screening visit of this study.
- •11)Any other condition which could warrant exclusion from the study, as per the investigator’s discretion.
- •12) Subjects who smoke and are pan eaters.
- •13) Subjects with hypersensitive teeth and with mobility greater than one as per miller tooth
- •mobility index.
- •14) Subjects having chipped teeth and defective restorations.
- •15) Subjects having deep periodontal pockets.
- •16) Subjects having bridgework in their teeth and dentures which interrupt during evaluation.
- •17) Subjects undergoing periodontal surgery within previous 6 months.
- •18) Subjects undergoing treatment with antibiotics, anti-inflammatory, anticonvulsants, anti histaminic, anti-depressant, anti-histaminic, sedatives, tranquilizers or daily analgesic drugs.
- •19) Subjects having uncontrolled metabolic disease.
- •20) Subjects overexposure to acidic by dietary and environment exposure.
研究者
相似试验
进行中（未招募）
1 期
A trial to investigate the efffect of a SGLT-2 inhibitor a DPP-4 inhibitor and a SGLT-2 inhibitor + DPP-4 inhibitor on glucagon levels, endogenous glucose production and lipolysis.Diabetes mellitus type 2MedDRA version: 19.0Level: LLTClassification code 10012594Term: DiabetesSystem Organ Class: 100000004861EUCTR2015-004637-27-ATMedizinische Universität Graz18
尚未招募
2 期
Bioequivalence study of Omega-3 fatty acids in healthy VolunteersCTRI/2024/03/063647Amway Global Services India Pvt Ltd
进行中（未招募）
Unknown
A clinical study to check the safety and effectiveness of test treatments in adult human subjects having anemia or iron-deficiency anemiaCTRI/2023/10/059283ORGENETICS INC
已完成
2 期
Efficacy study of Faulding's sea cucumer extracts in osteoarthritis.Musculoskeletal - OsteoarthritisOsteoarthritisACTRN12605000484640Faulding Healthcare Pty Ltd129
尚未招募
Unknown
This is a randomized, double-blind, three-arm, balanced, single-dose, parallel-group, Clinical Study to Compare the Pharmacokinetics, Safety, & Immunogenicity of pertuzumab biosimilar vs. Perjeta® (US & EU sourced) in normal, healthy, adult, human male subjects.CTRI/2023/06/054131Intas Pharmaceuticals Ltd Biopharma Division